J&J beats fourth-quarter earnings expectations, will release Covid vaccine data soon – CNBC

The business also said it would launch essential details on its coronavirus vaccine “soon. “We continue to progress our COVID-19 vaccine prospect and look forward to sharing details from our Phase 3 research study quickly. Unlike Pfizers and Modernas licensed vaccines, which need two doses offered about three to four weeks apart, J&Js requires just one dose.

The company also said it would launch essential details on its coronavirus vaccine “soon. “We continue to progress our COVID-19 vaccine candidate and look forward to sharing details from our Phase 3 study soon. Unlike Pfizers and Modernas licensed vaccines, which need 2 doses provided about three to four weeks apart, J&Js needs just one dosage.

Leave a Reply

Your email address will not be published. Required fields are marked *